Arora Sonia, Thavaselvam Duraipandian, Kumar Ashu, Prakash Archana, Barua Anita, Sathyaseelan Kannusamy
Division of Microbiology, Defence Research & Development Establishment, Jhansi Road, Gwalior 474 002 India.
Division of Microbiology, Defence Research & Development Establishment, Jhansi Road, Gwalior 474 002 India.
Diagn Microbiol Infect Dis. 2015 Feb;81(2):79-84. doi: 10.1016/j.diagmicrobio.2014.10.003. Epub 2014 Oct 22.
Melioidosis is an emerging infectious disease in India and caused by gram-negative, soil saprophyte bacteria Burkholderia pseudomallei. This disease is endemic in Southeast Asia and northern Australia, and sporadic cases of melioidosis are also reported from southern states of India. The present study reports the cloning, expression, and purification of recombinant protein outer membrane protein A (OmpA) of B. pseudomallei and its evaluation in indirect enzyme-linked immunosorbent assay (ELISA) format with 87 serum samples collected from Manipal, Karnataka, India. Twenty-three samples from culture confirmed cases (n=23) of melioidosis, 25 serum samples from patients of other febrile illness and pyrexia of unknown origin (n=25), and 39 serum samples from healthy blood donors (n=39) from Kasturba Medical College, Manipal, were tested in this assay format. The assay showed sensitivity of 82.6% and specificity of 93.75%. The recombinant OmpA based indirect ELISA will be a useful tool for serodiagnosis of melioidosis in large scale rapid screening of clinical samples.
类鼻疽是印度一种新出现的传染病,由革兰氏阴性土壤腐生菌伯克霍尔德菌引起。这种疾病在东南亚和澳大利亚北部流行,印度南部各邦也报告了类鼻疽散发病例。本研究报告了伯克霍尔德菌重组蛋白外膜蛋白A(OmpA)的克隆、表达和纯化,并采用间接酶联免疫吸附测定(ELISA)法,用从印度卡纳塔克邦马尼帕尔采集的87份血清样本对其进行了评估。本试验采用来自马尼帕尔卡斯图巴医学院的23份类鼻疽培养确诊病例样本(n=23)、25份其他发热性疾病和不明原因发热患者的血清样本(n=25)以及39份健康献血者的血清样本(n=39)。该检测方法的灵敏度为82.6%,特异性为93.75%。基于重组OmpA的间接ELISA将成为大规模快速筛查临床样本中类鼻疽血清学诊断的有用工具。